BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36838629)

  • 1. Rapid LC-MS/MS Bosutinib Quantification with Applications in Metabolic Stability Estimation.
    Attwa MW; Alanazi MM
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of In Silico and In Vitro Selpercatinib Metabolic Stability in Human Liver Microsomes Using a Validated LC-MS/MS Method.
    Attwa MW; AlRabiah H; Mostafa GAE; Bakheit AH; Kadi AA
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-MS/MS Estimation of Rociletinib Levels in Human Liver Microsomes: Application to Metabolic Stability Estimation.
    Attwa MW; Abdelhameed AS; Kadi AA
    Drug Des Devel Ther; 2021; 15():3915-3925. PubMed ID: 34552321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
    Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Rapid LC-MS/MS Method for Quantifying Alvocidib: In Silico and In Vitro Metabolic Stability Estimation in Human Liver Microsomes.
    Attwa MW; AlRabiah H; Kadi AA
    Molecules; 2023 Mar; 28(5):. PubMed ID: 36903615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple method for the determination of Bosutinib in rat plasma by UPLC-MS/MS.
    Xu Y; Huang XC; Dai S; Xiao Y; Zhou MT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Nov; 1004():93-7. PubMed ID: 26454795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of the irreversible fibroblast growth factor receptor inhibitor futibatinib by UPLC-MS/MS: Application to the metabolic stability assay in human liver microsomes for the estimation of its in vitro hepatic intrinsic clearance.
    Tang LWT; Chan ECY
    J Pharm Biomed Anal; 2022 May; 214():114731. PubMed ID: 35325798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an LC-MS/MS Method for Quantification of Sapitinib in Human Liver Microsomes: In Silico and In Vitro Metabolic Stability Evaluation.
    Attwa MW; AlRabiah H; Mostafa GAE; Kadi AA
    Molecules; 2023 Mar; 28(5):. PubMed ID: 36903565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-MS/MS method for the quantification of the anti-cancer agent infigratinib: Application for estimation of metabolic stability in human liver microsomes.
    Mostafa GAE; Kadi AA; AlMasoud N; Attwa MW; Al-Shakliah NS; AlRabiah H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122806. PubMed ID: 34325312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A highly efficient and sensitive LC-MS/MS method for the determination of afatinib in human plasma: application to a metabolic stability study.
    Kadi AA; Abdelhameed AS; Darwish HW; Attwa MW; Al-Shakliah NS
    Biomed Chromatogr; 2016 Aug; 30(8):1248-55. PubMed ID: 26683307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma pharmacokinetics and tissue distribution study of cajaninstilbene acid in rats by liquid chromatography with tandem mass spectrometry.
    Hua X; Fu YJ; Zu YG; Wu N; Kong Y; Li J; Peng X; Efferth T
    J Pharm Biomed Anal; 2010 Jun; 52(2):273-9. PubMed ID: 20116956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An LC-MS/MS method for the quantitation of cabozantinib in rat plasma: application to a pharmacokinetic study.
    Su Q; Li J; Ji X; Li J; Zhou T; Lu W; Li L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 985():119-23. PubMed ID: 25678398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution study of cisplatin in rat kidney and liver cancer tissues by using liquid chromatography electrospray ionization tandem mass spectrometry.
    Bandu R; Ahn HS; Lee JW; Kim YW; Choi SH; Kim HJ; Kim KP
    J Mass Spectrom; 2015 Jun; 50(6):844-53. PubMed ID: 26169139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of crenolanib in human serum and cerebrospinal fluid by liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS).
    Roberts MS; Turner DC; Owens TS; Ramachandran A; Wetmore C; Throm SL; Stewart CF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 929():1-5. PubMed ID: 23644495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a highly sensitive LC-ESI-MS/MS method for estimation of IIIM-MCD-211, a novel nitrofuranyl methyl piperazine derivative with potential activity against tuberculosis: Application to drug development.
    Magotra A; Sharma A; Gupta AP; Wazir P; Sharma S; Singh PP; Tikoo MK; Vishwakarma RA; Singh G; Nandi U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():200-206. PubMed ID: 28623772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid and sensitive LC/ESI-MS/MS method for quantitative analysis of docetaxel in human plasma and its application to a pharmacokinetic study.
    Yamaguchi H; Fujikawa A; Ito H; Tanaka N; Furugen A; Miyamori K; Takahashi N; Ogura J; Kobayashi M; Yamada T; Mano N; Iseki K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 893-894():157-61. PubMed ID: 22429876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of cyclobenzaprine in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry and its application in a pharmacokinetic study.
    Xiang Y; Zhou L; Qian Z; Peng K; Li D; Chen X; Jiang H; Zheng H
    Biomed Chromatogr; 2012 Sep; 26(9):1083-8. PubMed ID: 22120786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
    Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
    J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of an LC-MS/MS method for the determination of a novel thienoquinolin urea transporter inhibitor PU-48 in rat plasma and its application to a pharmacokinetic study.
    Zhang ZY; Wang X; Liu D; Zhang H; Zhang Q; Lu YY; Li P; Lou YQ; Yang BX; Lu C; Lou YX; Zhang GL
    Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29193233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous Determination of Bosentan, Glimepiride, HYBOS and M1 in Rat Plasma by UPLC-MS-MS and its Application to Pharmacokinetic Study.
    Chen M; Song W; Wang S; Chen Q; Pan P; Xu T; Hu G; Zheng Z
    J Chromatogr Sci; 2016 Aug; 54(7):1159-65. PubMed ID: 27240565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.